Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.20.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Current assets:    
Cash and cash equivalents $ 6,440 $ 10,790
Restricted cash 830 1,065
Accounts receivable, net of allowance for doubtful accounts of $1247 and $68, respectively 70,370 86,828
Manufacturing inventories 29,196 18,440
Service parts inventories 20,502 19,070
Other current assets 8,489 18,095
Total current assets 135,827 154,288
Long-term assets:    
Property and equipment, net 9,046 8,437
Restricted cash 5,000 5,000
Right-of-use assets, net 12,689 0
Other long-term assets 3,433 5,146
Total assets 165,995 172,871
Current liabilities:    
Accounts payable 36,949 37,395
Deferred revenue 81,492 90,407
Accrued restructuring charges 0 2,876
Long-term debt, current portion 7,321 1,650
Accrued compensation 14,957 17,117
Other accrued liabilities 17,535 29,025
Total current liabilities 158,254 178,470
Deferred revenue 37,443 36,733
Long-term debt, net of current portion 146,847 145,621
Operating lease liability 10,822 0
Other long-term liabilities 11,154 11,827
Total liabilities 364,520 372,651
Commitments and Contingencies (Note 10)
Preferred stock:    
Preferred stock, 20,000 shares authorized; no shares issued as of March 31, 2020 and 2019 0 0
Common stock:    
Common stock, $0.01 par value; 125,000 shares authorized; 39,905 and 36,040 shares issued and outstanding at March 31, 2020 and 2019, respectively 399 360
Additional paid-in capital 505,762 499,224
Accumulated deficit (703,164) (697,954)
Accumulated other comprehensive loss (1,522) (1,410)
Total stockholders' deficit (198,525) (199,780)
Total liabilities and stockholders' deficit $ 165,995 $ 172,871